We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current REGMF market cap is 758.32M. The company's latest EPS is CNY -7.9714 and P/E is -0.50.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 0 | 0 | 1.42B | 766.01M | 1.07B |
| Operating Income | -386.47M | -669.99M | 264.26M | 493.97M | 830.32M |
| Net Income | -430.28M | -697.82M | 276.26M | -998.83M | -1.51B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 689.31M | 4.12B | 4.16B | 6.02B | 5.53B |
| Total Liabilities | 921.28M | 523.07M | 712.79M | 1.04B | 2.09B |
| Total Equity | -231.97M | 3.59B | 3.45B | 4.98B | 3.44B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -282.75M | -660.08M | 263.63M | -1.26B | -1.5B |
| Investing | -95.1M | -479.07M | -637.95M | -851.09M | -816.66M |
| Financing | 407.32M | 3.9B | -626.9M | 2.42B | 978.31M |
| Market Cap | 758.32M |
| Price to Earnings Ratio | -0.50 |
| Price to Sales Ratio | 0.71 |
| Price to Cash Ratio | 1.04 |
| Price to Book Ratio | 0.22 |
| Dividend Yield | - |
| Shares Outstanding | 189.58M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -2.44% |
| 52 Week High | 4.10 |
| 52 Week Low | 2.01 |
| Spread (Intraday) | 2.2 (44%) |
| Company Name | RemeGen Company Ltd (PK) |
| Address |
40th floor, sunlight tower wan chai, wan chai |
| Website | https://www.remegen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
